Cardiac effect of thyrotoxicosis in acromegaly

Paolo Marzullo, Alberto Cuocolo, Diego Ferone, Rosario Pivonello, Marco Salvatore, Gaetano Lombardi, Annamaria Colao

Research output: Contribution to journalArticle

Abstract

Cardiac structure and function are affected both by acromegaly and hyperthyroidism. Whereas the former is mainly characterized by ventricular hypertrophy as well as diastolic and systolic impairment, the latter frequently leads to increased heart rate and enhancement of contractility and cardiac output. To further investigate this issue, we designed this two-arm study. In the first cross-sectional study, we compared echocardiography and radionuclide angiography results obtained in eight hyperthyroid acromegalic patients, eight hyperthyroid nonacromegalic patients, and eight healthy subjects. All acromegalic patients were receiving treatment for acromegaly at the onset of hyperthyroidism. In the second longitudinal study, performed in the group of acromegalic patients, we compared the cardiovascular results obtained during hyperthyroidism with the retrospective data obtained at the initial diagnosis of acromegaly and after 1-yr treatment for this disease and those prospective data obtained during the remission of hyperthyroidism. In the cross-sectional study, hyperthyroid acromegalic patients showed an increase in the left ventricular (LV) mass index (LVMi) compared to healthy and hyperthyroid controls (P <0.05), with evidence of LVMi hypertrophy in five of them (62.5%). A significant correlation was found between LVMi and GH levels (r = 0.785; P <0.05). The LV ejection fraction (LVEF) at rest was higher in the control hyperthyroid population than in healthy controls (P <0.05), whereas the LVEF response to exercise was reduced in acromegalic patients (P <0.05 vs. healthy controls). In acromegalics, the exercise-induced change in LVEF was significantly reduced compared to that in healthy controls (P <0.001), but not to that in hyperthyroid controls (P <0.07), being abnormal (

Original languageEnglish
Pages (from-to)1426-1432
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume85
Issue number4
DOIs
Publication statusPublished - 2000

Fingerprint

Acromegaly
Thyrotoxicosis
Hyperthyroidism
Echocardiography
Angiography
Hypertrophy
Radioisotopes
Cross-Sectional Studies
Exercise
Radionuclide Angiography
Cardiac Output
Stroke Volume
Longitudinal Studies
Healthy Volunteers
Heart Rate

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Cardiac effect of thyrotoxicosis in acromegaly. / Marzullo, Paolo; Cuocolo, Alberto; Ferone, Diego; Pivonello, Rosario; Salvatore, Marco; Lombardi, Gaetano; Colao, Annamaria.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 4, 2000, p. 1426-1432.

Research output: Contribution to journalArticle

Marzullo, Paolo ; Cuocolo, Alberto ; Ferone, Diego ; Pivonello, Rosario ; Salvatore, Marco ; Lombardi, Gaetano ; Colao, Annamaria. / Cardiac effect of thyrotoxicosis in acromegaly. In: Journal of Clinical Endocrinology and Metabolism. 2000 ; Vol. 85, No. 4. pp. 1426-1432.
@article{5a697872d4e648d7bb6fd3d78c963a66,
title = "Cardiac effect of thyrotoxicosis in acromegaly",
abstract = "Cardiac structure and function are affected both by acromegaly and hyperthyroidism. Whereas the former is mainly characterized by ventricular hypertrophy as well as diastolic and systolic impairment, the latter frequently leads to increased heart rate and enhancement of contractility and cardiac output. To further investigate this issue, we designed this two-arm study. In the first cross-sectional study, we compared echocardiography and radionuclide angiography results obtained in eight hyperthyroid acromegalic patients, eight hyperthyroid nonacromegalic patients, and eight healthy subjects. All acromegalic patients were receiving treatment for acromegaly at the onset of hyperthyroidism. In the second longitudinal study, performed in the group of acromegalic patients, we compared the cardiovascular results obtained during hyperthyroidism with the retrospective data obtained at the initial diagnosis of acromegaly and after 1-yr treatment for this disease and those prospective data obtained during the remission of hyperthyroidism. In the cross-sectional study, hyperthyroid acromegalic patients showed an increase in the left ventricular (LV) mass index (LVMi) compared to healthy and hyperthyroid controls (P <0.05), with evidence of LVMi hypertrophy in five of them (62.5{\%}). A significant correlation was found between LVMi and GH levels (r = 0.785; P <0.05). The LV ejection fraction (LVEF) at rest was higher in the control hyperthyroid population than in healthy controls (P <0.05), whereas the LVEF response to exercise was reduced in acromegalic patients (P <0.05 vs. healthy controls). In acromegalics, the exercise-induced change in LVEF was significantly reduced compared to that in healthy controls (P <0.001), but not to that in hyperthyroid controls (P <0.07), being abnormal (",
author = "Paolo Marzullo and Alberto Cuocolo and Diego Ferone and Rosario Pivonello and Marco Salvatore and Gaetano Lombardi and Annamaria Colao",
year = "2000",
doi = "10.1210/jc.85.4.1426",
language = "English",
volume = "85",
pages = "1426--1432",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Cardiac effect of thyrotoxicosis in acromegaly

AU - Marzullo, Paolo

AU - Cuocolo, Alberto

AU - Ferone, Diego

AU - Pivonello, Rosario

AU - Salvatore, Marco

AU - Lombardi, Gaetano

AU - Colao, Annamaria

PY - 2000

Y1 - 2000

N2 - Cardiac structure and function are affected both by acromegaly and hyperthyroidism. Whereas the former is mainly characterized by ventricular hypertrophy as well as diastolic and systolic impairment, the latter frequently leads to increased heart rate and enhancement of contractility and cardiac output. To further investigate this issue, we designed this two-arm study. In the first cross-sectional study, we compared echocardiography and radionuclide angiography results obtained in eight hyperthyroid acromegalic patients, eight hyperthyroid nonacromegalic patients, and eight healthy subjects. All acromegalic patients were receiving treatment for acromegaly at the onset of hyperthyroidism. In the second longitudinal study, performed in the group of acromegalic patients, we compared the cardiovascular results obtained during hyperthyroidism with the retrospective data obtained at the initial diagnosis of acromegaly and after 1-yr treatment for this disease and those prospective data obtained during the remission of hyperthyroidism. In the cross-sectional study, hyperthyroid acromegalic patients showed an increase in the left ventricular (LV) mass index (LVMi) compared to healthy and hyperthyroid controls (P <0.05), with evidence of LVMi hypertrophy in five of them (62.5%). A significant correlation was found between LVMi and GH levels (r = 0.785; P <0.05). The LV ejection fraction (LVEF) at rest was higher in the control hyperthyroid population than in healthy controls (P <0.05), whereas the LVEF response to exercise was reduced in acromegalic patients (P <0.05 vs. healthy controls). In acromegalics, the exercise-induced change in LVEF was significantly reduced compared to that in healthy controls (P <0.001), but not to that in hyperthyroid controls (P <0.07), being abnormal (

AB - Cardiac structure and function are affected both by acromegaly and hyperthyroidism. Whereas the former is mainly characterized by ventricular hypertrophy as well as diastolic and systolic impairment, the latter frequently leads to increased heart rate and enhancement of contractility and cardiac output. To further investigate this issue, we designed this two-arm study. In the first cross-sectional study, we compared echocardiography and radionuclide angiography results obtained in eight hyperthyroid acromegalic patients, eight hyperthyroid nonacromegalic patients, and eight healthy subjects. All acromegalic patients were receiving treatment for acromegaly at the onset of hyperthyroidism. In the second longitudinal study, performed in the group of acromegalic patients, we compared the cardiovascular results obtained during hyperthyroidism with the retrospective data obtained at the initial diagnosis of acromegaly and after 1-yr treatment for this disease and those prospective data obtained during the remission of hyperthyroidism. In the cross-sectional study, hyperthyroid acromegalic patients showed an increase in the left ventricular (LV) mass index (LVMi) compared to healthy and hyperthyroid controls (P <0.05), with evidence of LVMi hypertrophy in five of them (62.5%). A significant correlation was found between LVMi and GH levels (r = 0.785; P <0.05). The LV ejection fraction (LVEF) at rest was higher in the control hyperthyroid population than in healthy controls (P <0.05), whereas the LVEF response to exercise was reduced in acromegalic patients (P <0.05 vs. healthy controls). In acromegalics, the exercise-induced change in LVEF was significantly reduced compared to that in healthy controls (P <0.001), but not to that in hyperthyroid controls (P <0.07), being abnormal (

UR - http://www.scopus.com/inward/record.url?scp=0034458338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034458338&partnerID=8YFLogxK

U2 - 10.1210/jc.85.4.1426

DO - 10.1210/jc.85.4.1426

M3 - Article

C2 - 10770177

AN - SCOPUS:0034458338

VL - 85

SP - 1426

EP - 1432

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -